Member Info for Markshares

ORPH dont make a habit of releasing RNS during trading hours (I wish they would occasionally), and 1 trades are nonsense at the best of times!

Yes I noticed a number of rounded decent sized buys, interesting

Maybe they owned 115% of the company?

and it was 9th June, not 10th

They had about 13m not 593m!

Hahah no they didnt

Just a bit pathetic to bait people then when you get called up on it, change your tone slightly and avoid all questions, then when you are called up on that, go on to say you were "too busy trading" despite being probably the most active poster on the board today.

Also writing posts about being too busy to post is a bit of an oxymoron.

So now its the weekend lets hear your rationale for the SP falling below placing price, whenever the have the time of course.

Perhaps youve used the wrong terminology Valhalla, I doubt it is or will be the placees selling. Link/Acacia are not placees.

Why do you think Cathal needs to wait so long for a separation of the Immutex stake/possible NASDAQ listing and why wouldn't they have RNS'd their intentions to do so already?

Whatever happened to that £2.1m placing back on 6th June 2019? STILL no TR1 and no updated holdings in company unless I missed something? Did anyone ever raise it with Aidan?

I don't think it's clear they got it for well under 11p, 11p dead on maybe.

One trade, one misprint, one cancellation of misprint

IG offering quotes a plenty

Haha maybe.

Every buy is pushing up both bid and ask now.

Yes I agree, bidding would be unusual in that circumstance

Lets watch the price action into close. Would be good to get in on the bounce early. I suspect there are a lot of others watching in the sidelines thinking the same

Could just be a calm to allow demand to return

Whats your verdict? Clear? Has there been enough volume I wonder

Hows BEGO looking JohnHenry?

Confirms that it is definitely Avacta is the one selling, says had they approached him directly they could have easily found a buyer from the recent raise.